Summary
Corteva, Inc. (CTVA) filed an 8-K on August 1, 2019, to provide investors with unaudited pro forma combined financial information. This filing is crucial as it offers historical financial data on a basis consistent with how Corteva will report its financial results as an independent, publicly traded company following its separation from DowDuPont (now DuPont de Nemours, Inc.). The pro forma statements adjust for significant historical events including the DowDuPont merger, internal reorganizations, debt retirement transactions, and the Corteva Distribution itself, presenting financial performance as if these events had occurred on January 1, 2016. This disclosure is intended to equip the financial community with tools to understand Corteva's operational performance and strategic decisions by providing a more consistent historical financial narrative. Investors should review this information, particularly Exhibit 99.1 containing the pro forma income statements and segment information, in conjunction with Corteva's Form 10 registration statement to gain a comprehensive understanding of the company's historical financial position and performance as a standalone entity.
Key Highlights
- 1Corteva, Inc. (CTVA) became an independent public company on June 1, 2019, following its separation from DowDuPont.
- 2The 8-K provides unaudited pro forma combined financial statements and historical segment information.
- 3The pro forma data adjusts for significant corporate events: the DowDuPont merger, internal reorganizations, debt retirement transactions, and the Corteva Distribution.
- 4The pro forma information is presented as if these events occurred on January 1, 2016, to ensure a consistent historical reporting basis.
- 5This disclosure is furnished under Regulation FD to provide the financial community with tools for analysis and performance evaluation.
- 6The furnished information is for informational purposes and is not intended to project future performance.
- 7Investors are advised to read this information in conjunction with Corteva's Form 10 registration statement.